Solid Biosciences Inc. is a life sciences company focused on advancing a portfolio of gene therapy candidates for neuromuscular and cardiac diseases, including Duchenne muscular dystrophy.

Solid Biosciences

Solid Biosciences Inc.

Solid Biosciences | 9,368 followers on LinkedIn. #TogetherWeAreSolid | Solid Biosciences is a life science company focused on advancing a portfolio of neuromuscular and cardiac programs for the treatment of devastating diseases, including Duchenne, Friedreich’s ataxia, BAG3 mediated dilated cardiomyopathy, and additional cardiac diseases. We aim to be the center of excellence across the entire disease spectrum, serving as a catalyst to bring together those with the expertise in science, technology, disease management and care. Disease-focused and founded by a family directly impacted, our mandate is simple yet comprehensive - attack the roots of the disease and improve daily life for patients.

Corporate Evolution - Project Leadership Expert

Alisha (Uhlenbrock-)Fürst, MBA (she/her/hers)

Talent Advisor at Solid Biosciences

Kristen Pinkston (Harris)

Sharon McGonigle

Chief Technology Officer at Solid Biosciences, Inc.

Paul Herzich

Solid Biosciences will be participating in upcoming community webinars to discuss our INSPIRE DUCHENNE clinical study and provide important updates. Join us to hear from our team members Annie Ganot , Patrick Gonzalez , and Matthew Harmelink as they share insights and answer questions. Webinar Schedule: - Parent Project Muscular Dystrophy Webinar: Tuesday, November 12, at 1 PM ET, https://lnkd.in/ekBKj9K4 - Defeat Duchenne Canada Webinar: Wednesday, November 13, at 1 PM ET, https://lnkd.in/e-ZF3mEe - Jett Foundation Webinar: Thursday, November 21, at 1 PM ET, https://lnkd.in/epBSAjeg Don’t miss these opportunities to learn more about our study. We look forward to connecting with you! #SolidBiosciences #DuchenneMuscularDystrophy #DuchenneAwareness #RareDiseaseResearch

Solid Biosciences is proud to sponsor the 2024 International SADS Foundation Conference! We are looking forward to connecting with the patients, families, and clinicians, on November 8-9 at Lurie Children’s Hospital in Chicago, IL. Learn more and register here: https://lnkd.in/gdsP9tzG The SADS Foundation #SADSFoundation #HeartHealth22

Solid is pleased to share an update with the Duchenne community on our INSPIRE DUCHENNE clinical trial. We're grateful to the study participants, their families, and our clinical site partners for their important contributions to scientific research. To read the full letter and learn about our upcoming community webinars, visit: https://lnkd.in/edJkS4x9 #DuchenneAwareness #RareDiseaseResearch #DuchenneCommunity

Solid Biosciences today announced its financial results for Q3 2024 and shared a business update. Read the full press release: https://lnkd.in/eW3uuE77

Attending the Truist Securities BioPharma Symposium? Join us on Thursday, November 7th as our Chief Medical Officer, Gabriel Brooks , MD, takes part in the Genetic Medicine Panel from 1:45 – 2:25 PM ET. Together with leading experts, he’ll discuss the evolution of drug development, targeted strategies for genetic diseases, and the key clinical and commercialization hurdles in bringing innovative genetic medicines to life. To learn more and register, visit: https://lnkd.in/e4-atWBy #GeneticMedicine #TruistSecurities

Join us Wednesday, November 13 at 1 p.m. ET, for the latest information from Solid Biosciences during their free webinar: INSPIRE DUCHENNE Community Update. The Solid Biosciences team will present an update on the INSPIRE DUCHENNE clinical trial for SGT-003, a next-generation microdystrophin gene therapy for individuals living with #Duchenne #musculardystrophy . Register for this free webinar today: https://bit.ly/4fbWyw7 .

Defeat Duchenne Canada

Planning to attend Chardan ’s 8th Annual Genetic Medicines Conference? Join Solid President and CEO Bo Cumbo , and Gabriel Brooks , M.D., Chief Medical Officer, for a fireside chat on Monday, September 30, at 11:00 AM ET. You can also tune in to the live webcast on our Events page: https://lnkd.in/eJXs83j #GeneticMedicine #Chardan

Solid is proud to be a sponsor of the Western Canadian Neuromuscular Conference . Join us in Calgary, AB, from September 27-29. We'll have Matthew Harmelink representing Solid at the event, ready to connect and engage with the neuromuscular community. Check out the conference details at: wcnmc.ca #WCNMC2024 #Neuromuscular

We are proud to share that Solid is a sponsor of Defeat Duchenne Canada 's 2024 Family Forum! This year's forum provides a weekend of free educational sessions for families and caregivers to gather and learn more about the latest advancements in research, clinical trials, care, and advocacy from leading experts. The event will be held September 21-22 at The Bayview Yards in Ottawa, Ontario, and will also be streamed online. To learn more, visit: https://lnkd.in/ebVQ2P-C #DuchenneAwarenessMonth #DuchenneMuscularDystrophy

Solid President and CEO, Bo Cumbo , and Chief Medical Officer, Gabriel Brooks , M.D., will be participating in a fireside chat at the 2024 Cantor Fitzgerald Global Healthcare Conference tomorrow, September 18, at 10:20 AM ET. Catch the live webcast on our Events page: https://lnkd.in/eJXs83j #CantorFitzgerald

SOLI

COM:SOLIDBIO:INVESTORS

Solid Biosciences Inc.

locale

market

industry

website

crunchbase

linkedin

investor of

Metrics